Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1982 Nov;38(2):399–407. doi: 10.1128/iai.38.2.399-407.1982

Intrathecal synthesis of virus antibodies in multiple sclerosis patients.

T Arnadottir, M Reunanen, A Salmi
PMCID: PMC347752  PMID: 7141701

Abstract

A follow-up study on the intrathecal synthesis of viral antibodies in multiple sclerosis patients was made on 28 patients over a period of about 2 years. Serial serum and cerebrospinal fluid specimens were assayed for antibodies against measles, rubella, parainfluenza type 2, respiratory syncytial, mumps, influenza A, influenza B, adeno, and herpes simplex viruses by employing a solid-phase enzyme immunoassay technique. All patients had local antibody synthesis against one or more of the antigens studied. Rubella and measles virus antibodies were found with the highest frequency and were synthesized at the highest rate. Simultaneous intrathecal antibody synthesis against the greater number of the viruses studied was associated with higher local immunoglobulin G synthesis. A good overall correspondence in the fluctuations of the different viral antibodies synthesized intrathecally was usually found. Sometimes the changes in intrathecal antibody levels correlated well with the changes in immunoglobulin G index and sometimes not. These fluctuations could not be correlated with the clinical course of the disease. The results of this study suggest that the viral antibodies studied are not relevant to the etiology or the pathogenesis of multiple sclerosis.

Full text

PDF
399

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnadottir T., Reunanen M., Meurman O., Salmi A., Panelius M., Halonen P. Measles and rubella virus antibodies in patients with multiple sclerosis. A longitudinal study of serum and CSF specimens by radioimmunoassay. Arch Neurol. 1979 May;36(5):261–265. doi: 10.1001/archneur.1979.00500410039004. [DOI] [PubMed] [Google Scholar]
  2. Bloom B. R. Immunological changes in multiple sclerosis. Nature. 1980 Sep 25;287(5780):275–276. doi: 10.1038/287275a0. [DOI] [PubMed] [Google Scholar]
  3. Delpech B., Lichtblau E. Etude quantitative des immunoglobulines G et de l'albumine du liquide cephalo rachidien. Clin Chim Acta. 1972 Mar;37:15–23. doi: 10.1016/0009-8981(72)90410-x. [DOI] [PubMed] [Google Scholar]
  4. Detels R., Myers L. W., Ellison G. W., Visscher B. R., Malmgren R. M., Madden D. L., Sever J. L. Changes in immune response during responses in MS patients. Neurology. 1981 Apr;31(4):492–495. doi: 10.1212/wnl.31.4.492. [DOI] [PubMed] [Google Scholar]
  5. FRICK E., SCHEID-SEYDEL L. Untersuchungen mit J 131-markiertem gamma-Globulin zur Frage der Abstammung der Liquoreiweisskörper. Klin Wochenschr. 1958 Sep 15;36(18):857–863. doi: 10.1007/BF01485232. [DOI] [PubMed] [Google Scholar]
  6. Forghani B., Cremer N. E., Johnson K. P., Ginsberg A. H., Likosky W. H. Viral antibodies in cerebrospinal fluid of multiple sclerosis and control patients: comparison between radioimmunoassay and conventional techniques. J Clin Microbiol. 1978 Jan;7(1):63–69. doi: 10.1128/jcm.7.1.63-69.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ganrot K., Laurell C. B. Measurement of IgG and albumin content of cerebrospinal fluid, and its interpretation. Clin Chem. 1974 May;20(5):571–573. [PubMed] [Google Scholar]
  8. Halonen P., Bennich H., Torfason E., Karlsson T., Ziola B., Matikainen M. T., Hjertsson E., Wesslen T. Solid-phase radioimmunoassay of serum immunoglobulin A antibodies to respiratory syncytial virus and adenovirus. J Clin Microbiol. 1979 Aug;10(2):192–197. doi: 10.1128/jcm.10.2.192-197.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hershey L. A., Gado M. H., Trotter J. L. Computerized tomography in the diagnostic evaluation of multiple sclerosis. Ann Neurol. 1979 Jan;5(1):32–39. doi: 10.1002/ana.410050106. [DOI] [PubMed] [Google Scholar]
  10. Hänninen P., Arstila P., Lang H., Salmi A., Panelius M. Involvement of the central nervous system in acute, uncomplicated measles virus infection. J Clin Microbiol. 1980 Jun;11(6):610–613. doi: 10.1128/jcm.11.6.610-613.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ilonen J., Herva E., Reunanen M., Panelius M., Meurman O., Arstila P., Tiilikainen A. HLA antigens and antibody responses to measles and rubella viruses in multiple sclerosis. Acta Neurol Scand. 1977 Apr;55(4):299–309. doi: 10.1111/j.1600-0404.1977.tb05649.x. [DOI] [PubMed] [Google Scholar]
  12. Kalimo K. O., Ziola B. R., Viljanen M. K., Granfors K., Toivanen P. Solid-phase radioimmunoassay of herpes simplex virus IgG and IgM antibodies. J Immunol Methods. 1977;14(2):183–195. doi: 10.1016/0022-1759(77)90008-4. [DOI] [PubMed] [Google Scholar]
  13. Laitinen O., Vaheri A. Very high measles and rubella virus antibody titres associated with hepatitis, systemic lupus erythematosus, and infectious mononucleosis. Lancet. 1974 Feb 9;1(7850):194–197. doi: 10.1016/s0140-6736(74)92496-9. [DOI] [PubMed] [Google Scholar]
  14. Link H. Immunoglobulin G and low molecular weight proteins in human cerebrospinal fluid. Chemical and immunological characterisation with special reference to multiple sclerosis. Acta Neurol Scand. 1967;43(Suppl):1–136. [PubMed] [Google Scholar]
  15. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  16. Mattson D. H., Roos R. P., Arnason B. G. Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains. Nature. 1980 Sep 25;287(5780):335–337. doi: 10.1038/287335a0. [DOI] [PubMed] [Google Scholar]
  17. Mehta P. D., Thormar H., Wisniewski H. M. Quantitation of measles-specific IgG. Its presence in CSF and brain extracts of patients with multiple sclerosis. Arch Neurol. 1980 Oct;37(10):607–609. doi: 10.1001/archneur.1980.00500590031002. [DOI] [PubMed] [Google Scholar]
  18. Meurman O. H., Sarkkinen H. K., Puhakka H. J., Virolainen E. S., Meurman O. H. Local IgA-class antibodies against respiratory viruses in middle ear and nasopharyngeal secretions of children with secretory otitis media. Laryngoscope. 1980 Feb;90(2):304–311. doi: 10.1288/00005537-198002000-00016. [DOI] [PubMed] [Google Scholar]
  19. Meurman O. H., Ziola B. R. IgM-class rheumatoid factor interference in the solid-phase radioimmunoassay of rubella-specific IgM antibodies. J Clin Pathol. 1978 May;31(5):483–487. doi: 10.1136/jcp.31.5.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Norrby E., Link H., Olsson J. E., Panelius M., Salmi A., Vandvik B. Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis. Infect Immun. 1974 Oct;10(4):688–694. doi: 10.1128/iai.10.4.688-694.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Norrby E. Viral antibodies in multiple sclerosis. Prog Med Virol. 1978;24:1–39. [PubMed] [Google Scholar]
  22. Olsson J. E., Link H., Müller R. Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: disability, duration and age of onset. J Neurol Sci. 1976 Feb;27(2):233–245. doi: 10.1016/0022-510x(76)90064-2. [DOI] [PubMed] [Google Scholar]
  23. Olsson J. E., Pettersson B. A comparison between agar gel electrophoresis and CSF serum quotients of IgG and albumin in neurological disease. Acta Neurol Scand. 1976 Apr;53(4):308–322. doi: 10.1111/j.1600-0404.1976.tb04350.x. [DOI] [PubMed] [Google Scholar]
  24. Pettersson U., Philipson L., Höglund S. Structural proteins of adenoviruses. I. Purification and characterization of the adenovirus type 2 hexon antigen. Virology. 1967 Dec;33(4):575–590. doi: 10.1016/0042-6822(67)90057-8. [DOI] [PubMed] [Google Scholar]
  25. Reunanen M., Arstila P., Hakkarainen H., Nikoskelainen J., Salmi A., Panelius M. A longitudinal study on antibodies to measles and rubella viruses in patients with multiple sclerosis. A preliminary report. Acta Neurol Scand. 1976 Oct;54(4):366–370. doi: 10.1111/j.1600-0404.1976.tb04366.x. [DOI] [PubMed] [Google Scholar]
  26. Roström B., Link H., Laurenzi M. A., Kam-Hansen S., Norrby E., Wahren B. Viral antibody activity of oligoclonal and polyclonal immunoglobulins synthesized within the central nervous system in multiple sclerosis. Ann Neurol. 1981 Jun;9(6):569–574. doi: 10.1002/ana.410090610. [DOI] [PubMed] [Google Scholar]
  27. SCHUMACHER G. A., BEEBE G., KIBLER R. F., KURLAND L. T., KURTZKE J. F., MCDOWELL F., NAGLER B., SIBLEY W. A., TOURTELLOTTE W. W., WILLMON T. L. PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS. Ann N Y Acad Sci. 1965 Mar 31;122:552–568. doi: 10.1111/j.1749-6632.1965.tb20235.x. [DOI] [PubMed] [Google Scholar]
  28. Salmi A., Panelius M., Vainionpä R. Antibodies against different viral antigens in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Acta Neurol Scand. 1974;50(2):183–193. doi: 10.1111/j.1600-0404.1974.tb02771.x. [DOI] [PubMed] [Google Scholar]
  29. Salmi A., Viljanen M., Reunanen M. Intrathecal synthesis of antibodies to diphtheria and tetanus toxoids in multiple sclerosis patients. J Neuroimmunol. 1981 Sep;1(3):333–341. doi: 10.1016/0165-5728(81)90036-9. [DOI] [PubMed] [Google Scholar]
  30. Tibbling G., Link H., Ohman S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest. 1977 Sep;37(5):385–390. doi: 10.1080/00365517709091496. [DOI] [PubMed] [Google Scholar]
  31. Vandvik B., Degré M. Measles virus antibodies in serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders, with special reference to measles antibody synthesis within the central nervous system. J Neurol Sci. 1975 Feb;24(2):201–219. doi: 10.1016/0022-510x(75)90233-6. [DOI] [PubMed] [Google Scholar]
  32. Vandvik B., Norrby E., Nordal H. J., Degré M. Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis. Scand J Immunol. 1976;5(8):979–992. doi: 10.1111/j.1365-3083.1976.tb03050.x. [DOI] [PubMed] [Google Scholar]
  33. Vartdal F., Vandvik B., Norrby E. Viral and bacterial antibody responses in multiple sclerosis. Ann Neurol. 1980 Sep;8(3):248–255. doi: 10.1002/ana.410080305. [DOI] [PubMed] [Google Scholar]
  34. Ziola B., Meurman O., Matikainen M. T., Salmi A., Kalliomäki J. L. Determination of human immunoglobulin M rheumatoid factor by a solid-phase radioimmunoassay which uses human immunoglobulin G in antigen-antibody complexes. J Clin Microbiol. 1978 Aug;8(2):134–141. doi: 10.1128/jcm.8.2.134-141.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ziola B., Reunanen M., Salmi A. IgM-class rheumatoid factor in serum and cerebrospinal fluid of multiple sclerosis and matched neurological control patients. J Neurol Sci. 1981 Jul;51(1):101–109. doi: 10.1016/0022-510x(81)90063-0. [DOI] [PubMed] [Google Scholar]
  36. Ziola B., Salmi A., Panelius M., Halonen P. Measles virus-specific IgM antibodies and IgM-class rheumatoid factor in serum and cerebrospinal fluid of subacute sclerosing panencephalitis patients. Clin Immunol Immunopathol. 1979 Aug;13(4):462–474. doi: 10.1016/0090-1229(79)90089-8. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES